Avadel Pharmaceuticals (AVDL) Net Income: 2009-2021
Historic Net Income for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2021 value amounting to -$23.1 million.
- Avadel Pharmaceuticals' Net Income fell 894.24% to -$23.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$88.2 million, marking a year-over-year decrease of 514.63%. This contributed to the annual value of -$85.5 million for FY2021, which is 1253.58% down from last year.
- As of Q4 2021, Avadel Pharmaceuticals' Net Income stood at -$23.1 million, which was up 9.85% from -$25.7 million recorded in Q3 2021.
- Avadel Pharmaceuticals' 5-year Net Income high stood at $45.7 million for Q2 2020, and its period low was -$63.9 million during Q4 2018.
- Moreover, its 3-year median value for Net Income was -$12.4 million (2019), whereas its average is -$11.9 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Net Income spiked by 630.81% in 2020, and later crashed by 894.24% in 2021.
- Avadel Pharmaceuticals' Net Income (Quarterly) stood at -$8.2 million in 2017, then slumped by 674.52% to -$63.9 million in 2018, then climbed by 28.68% to -$45.5 million in 2019, then soared by 94.89% to -$2.3 million in 2020, then crashed by 894.24% to -$23.1 million in 2021.
- Its last three reported values are -$23.1 million in Q4 2021, -$25.7 million for Q3 2021, and -$23.3 million during Q2 2021.